Skip to main content
Shoulder & Elbow logoLink to Shoulder & Elbow
. 2016 Mar 8;8(3):151–157. doi: 10.1177/1758573216632464

Ten questions on prosthetic shoulder infection

Elizabeth M Pinder 1, Joshua CY Ong 1, R Stephen Bale 1, Ian A Trail 1,
PMCID: PMC4950280  PMID: 27583013

Abstract

Prosthetic shoulder infection can cause significant morbidity secondary to pain and stiffness. Symptoms may be present for years before diagnosis because clinical signs are often absent and inflammatory markers may be normal. An emerging common culprit, Propionibacterium acnes, is hard to culture and so prolonged incubation is necessary. A negative culture result does not always exclude infection and new synovial fluid biochemical markers such as α defensin are less sensitive than for lower limb arthroplasty. A structured approach is necessary when assessing patients for prosthetic shoulder joint infection. This includes history, examination, serum inflammatory markers, plain radiology and aspiration and/or biopsy. A classification for the likelihood of prosthetic shoulder infection has been described based on culture, pre-operative and intra-operative findings. Treatment options include antibiotic suppression, debridement with component retention, one-stage revision, two-stage revision and excision arthroplasty. Revision arthroplasty is associated with the best outcomes.

Keywords: chronic infection, clinical assessment, Propionibacterium acnes, prosthetic shoulder infection, revision arthroplasty, shoulder arthroplasty infection

Introduction

Shoulder arthroplasty has become increasingly popular over the last decade. In 2013, the National Joint Registry for England, Wales & Northern Ireland recorded 3880 primary shoulder replacements.1 As a result of this increase in volume, the incidence of prosthetic shoulder infection is expected to rise.

Compared with its lower limb equivalent, the identification of chronic infection around a prosthetic shoulder joint is more challenging. Clinical signs may be absent, biochemical markers normal and the organism difficult to culture.2,3 Nevertheless, a logical stepwise approach is necessary when considering the aetiology of persistent pain, and infection should always be included in the differential diagnosis. We pose ten questions with respect to prosthetic shoulder infection, thus providing a structure for the evaluation and management of the symptomatic patient.

1. How common is prosthetic shoulder infection?

The reported infection rate following anatomic total shoulder replacement is 1% to 3.9%.4 For reverse polarity designs, it is higher due to an increase in dead space and haematoma formation.5,6 Historically, up to 15.3% were affected, although this has improved over the last decade to 1% to 8%.713 The National Joint Registry recorded ‘infection’ as the indication in 12% of revision shoulder operations in 2013.14 The true rate is likely to be higher because some intra-operative specimens may subsequently grow organisms.

2. What are the risk factors?

A recent multicentre study identified the following risk factors: young age, male sex and arthroplasty for trauma.15 In contrast to other studies, there was no correlation with the American Society of Anesthesiologist score.4,16,17 A further study of over 200,000 patients identified ‘superobesity’ as a risk factor.18

It is accepted that revision surgery increases the risk of infection, the incidence of which is as high as 15%.1922 The actual value may be higher because infection may be unrecognized and misclassified as aseptic failure.23 Reverse designs are six times more likely to become infected compared to unconstrained total shoulder arthroplasty.15

3. What is the likely organism?

Prosthetic shoulder infections may be acute or chronic. Chronic infections tend to involve low-grade, low-virulence organisms that do not elicit a pronounced inflammatory response.24 In contrast to lower limb joints, the infecting organism for shoulders is commonly Propionibacterium acnes (P. Acnes), and is present in 17.6% to 60% of cases.2427 Other common organisms include Staphylococcus epidermidis and Staphylococcus aureus (Table 1).

Table 1.

Common infecting organisms in prosthetic shoulder infection.

Study and Year Organism on tissue culture Number %
Singh et al.26 (2012) Coagulase negative Staphylococcus aureus 3 21.4
Propionibacterium acnes 3 21.4
Staphylococcus aureus 3 21.4
Clostridium 1 7.1
Pseudomonas spp. 1 7.1
Bacillus sp. 1 7.1
Enterococcus 1 7.1
Methicillin-resistant Staphylococcus aureus 1 7.1
Sabesan et al.27 (2011) Coagulase negative Staphylococcus aureus 4 23.5
Propionibacterium acnes 3 17.6
Staphylococcus epidermidis and Proprionibacterium acnes 2 11.8
Enterococcus 2 11.8
Serratiamarcescens 1 5.9
Pseudomonas and Staphylococcus epidermidis 1 5.9
Providencia and Enterococcus faecalis 1 5.9
Unavailable 3 17.6
Piper et al.25 (2009) Propionibacterium acnes 7 38.9
Coagulase negative Staphylococcus spp. 5 27.8
Staphylococcus aureus 4 22.2
Pseudomonas aeruginosa 1 5.6
Corynebacterium sp. 1 5.6
Grosso et al.24 (2014) Propionibacterium acnes 18 60.0
Non-Propionibacterium acnes 12 40.0

4. What are the signs and symptoms of chronic infection?

Diagnosing chronic prosthetic joint infection can be challenging. Pain, stiffness or both may be the only symptoms.28 Patients may complain of ongoing inadequate pain relief following index surgery, or of deterioration after an initial successful result. Symptoms may be longstanding, even for several years, given their often low level nonspecific nature.22 In contrast to acute infections, examination of the joint may be unremarkable. Signs suggestive of an acute infection include pyrexia, sinus, increased warmth, swelling and erythema.

5. How should the patient be assessed in clinic?

A thorough history is mandatory, including details of presenting local and systemic symptoms, risk factors, previous operations and related complications, past medical history and medications. There may be a history of wound infection following previous surgery. Clinical signs of infection should be assessed: increased warmth, erythema, swelling, sinuses, reduced range of movement and pyrexia. Other non-infective causes of the symptoms should be considered, such as component malposition, mechanical failure or referred pain from adjacent areas.

A diagnosis of periprosthetic infection should be considered in any patient with unexplained persistent and intrusive pain. Baseline biochemical tests should be requested, including C-reactive protein (CRP), estimated sedimentation rate (ESR) and white cell count. Although specific, these tests are not sensitive.2,29 Thus, an elevated result is strongly suggestive of periprosthetic infection (in the absence of another cause), although normal values do not exclude the diagnosis.

Plain radiographs are recommended. Implants should be inspected for subsidence, alignment and osteolysis.30 Loosening of a recently implanted prosthesis increases the suspicion of infection, although images are often normal.31 Computerized tomography allows superior assessment of bone stock, bone perforations, component malposition and component migration.30 Radionucleotide bone scans are generally not considered as sufficiently sensitive to be diagnostic of infection.32

6. What should I do if the patient has persistent unexplained pain but all investigations are normal?

The patient should be offered synovial fluid aspiration and arthroscopic or open biopsy for culture and histology if it is dry.3,28 The presence of synovitis, metallosis, loose bodies, adhesions, rotator cuff integrity and glenoid stability should be noted intra-operatively.3 Some studies have suggested that at least three tissue specimens in direct contact with the implant should be obtained, whereas others recommend at least four.3,33 We advocate five separate samples, which are collected in a universal container and transported to the laboratory as soon as practically possible. Each specimen should be obtained with a different scalpel and tissue forceps which are then immediately discarded. The common culprit, P. acnes is difficult to culture because it is slow growing therefore incubation times should be a minimum of 14 days.28,3436 An even longer incubation time has been suggested, although this increases the risk of contamination.37,38 Laboratory processing of the samples and transfer to broth should ideally occur in high-efficiency particulate laminar airflow followed by 16 days of incubation. Frozen section analysis of samples should also be requested and the number of polymorphonuclear leukocytes (PMN) per high power field (×400) be counted. Traditional diagnostic criteria are less sensitive for P. acnes compared to other organisms (50% and 67%) but may be optimized by increasing the threshold to 10 PMN per five high power fields (72% and 75%).24

A relatively recent development involves synovial fluid analysis for biomarkers such as α defensin and interleukin-6. Several studies have considered the role of α defensin in the evaluation of painful hip and knee replacements with a sensitivity and specificity at (or approaching) 100%.3941 These results have not been replicated for shoulder replacements, with sensitivity dropping to 63%.42 Furthermore, inadequate volumes were aspirated in 25%. Interleukin-6 may be a useful alternative, potentially avoiding the morbidity of an open biopsy. Frangiamore et al.43 report a sensitivity of 87% and specificity of 90% for shoulder arthroplasty.

7. How do I interpret these results: is it infected?

Isolating the same organism in several tissue samples is strongly suggestive of infection. The difficulty arises when only one specimen is positive as it may represent sample contamination. Conversely, infection may still be present even when cultures are negative.

These diagnostic challenges led to the development of the Musculoskeletal Infection Society (MSIS) Criteria for knee and hip prosthetic joint infections (Table 2).44 When applying this classification, a diagnosis of infection is still possible, despite negative culture results, as long as there is a combination of other clinical, biochemical and histological positive results. More recently, a shoulder specific classification was described dividing patients into the following groups: definite infection, probable infection, probable contaminant, no evidence for infection (Table 3).24,43 Although ‘definite infection’ still requires at least two positive microbial culture results of the same organism, the identification of an organism in only one sample still allows a diagnosis of ‘probable infection’ as long as there is at least one positive pre-operative or intra-operative finding of infection. These positive findings are: swelling, sinus tract, redness, drainage, positive ESR or CRP, intra-operative gross findings (purulent drainage, necrosis) and positive intra-operative frozen section. Thus, a shoulder with no clinical signs of infection, normal inflammatory markers and normal radiographic appearances can be ‘probably infected’ as long as there is one intra-operative positive culture and a positive intra-operative frozen section result.

Table 2.

Musculoskeletal Infection Society (MSIS) criteria for hip and knee prosthetic joint infections.44

1. A sinus tract communicating with the prosthesis; OR
2. A pathogen isolated by culture from two separate tissue or fluid samples obtained from the affected prosthetic joint; OR
3. Four of the following six criteria exist:
 a. Elevated serum erythrocyte sedimentation rate or serum C-reactive protein concentration
 b. Elevated synovial white blood cell count
 c. Elevated synovial neutrophil percentage (polymorphonuclear leukocyte %)
 d. Presence of purulence in the affected joint
 e. Isolation of a microorganism in one culture of periprosthetic tissue or fluid
 f. Greater than five neutrophils per high-power field in five high-power fields observed from histological analysis of periprosthetic tissue at 400 times magnification

Table 3.

Periprosthetic shoulder infection criteria described by Frangiamore et al.43

Category Criteria*
Definite infection At least one positive pre-operative or intra-operative finding of infection and multiple positive intra-operative cultures with the same organism OR One positive pre-operative (aspirate) culture and one positive intra-operative culture with the same organism
Probable infection At least one positive pre-operative or intra-operative finding of infection and one positive intra-operative culture OR No pre-operative or intra-operative findings of infection and multiple positive intra-operative cultures with the same organism
Probable contaminant No pre-operative or intra-operative findings of infection and one positive intra-operative culture
No evidence for infection No pre-operative or intra-operative findings of infection and no positive intra-operative cultures
*

Pre-operative or intra-operative findings of infection: pre-operative clinical signs (swelling, sinus tract, redness, drainage), positive erythrocyte sedimentation rate or C-reactive protein value, intra-operative gross findings (purulent drainage, necrosis), positive intra-operative frozen section.

8. What are the treatment options?

Treatment depends on the chronicity of infection, isolation of an organism, organism virulence, component stability and patient fitness for surgery. By definition, early infections occur within 3 months of surgery, sub-acute within 3 months to 12 months and late infections after 12 months.22

If a patient has co-morbidities preventing surgery, antibiotic suppression is the only option. Surgical alternatives include debridement and retention of the prosthesis, one-stage revision, two-stage revision and excision arthroplasty. The former may be considered for early infections with a known low-virulence organism, although there is a high risk of persistent infection,22,45 especially if performed arthroscopically.21 Weber et al.16 achieved eradication of infection with the use of vacuum irrigation therapy, although multiple visits to theatre were required. Open or arthroscopic washout for late infections is associated with poor results.21 Revision to another shoulder prosthesis, either via one or two stages, is preferable because functional outcomes are superior.21,22

Several studies report good outcomes following one-stage revision surgery.4648 Ideally the organism should be known pre-operatively and be of low virulence. Successful outcomes may still be achieved without an isolate because the organism was unknown in almost 20% of patients in a study by Ince et al.47 They state that infection was eradicated in all 12 of their patients at a mean of 5.8 years follow-up. Three required revision surgery for non-infective complications. A success rate of 94% was reported by Klatte et al.48 at a mean follow up of 4.7 years. The advantages of this method include immediate reconstruction with reduced morbidity, minimization of adhesions and lower cost.37

An alternative is two-stage revision surgery. Ghijselings et al.49 report one fairly satisfactory and two satisfactory results in their case series. Another study reports eradication of infection in all three of their patients, whereas Coste et al.21 and Sperling et al.22 achieved this in six out of 10. There was a 20-point improvement in Constant score, although this was less marked than the improvement in the one-stage group. The advantages of this method are that microbiology and histology results are known prior to reimplantation and the explant can undergo sonification (if available) prior to culture.25 Furthermore, the second stage can be scheduled once serum inflammatory markers are normal, which is particularly useful for higher virulence organisms with a more pronounced inflammatory response. The disadvantage is the higher physiological strain for patients, soft tissue contractures and loss of bone stock.17,21,50

The superiority of one- or two-stage revision is difficult to establish because the evidence is mostly limited to case series. A study by Cuff et al.10 did compare these methods retrospectively. An eradication rate of 100% was reported in both groups and no statistically significant difference in outcome measures were found. A potential criticism, however, is the inclusion of five infected cuff repairs in addition to 17 hemiarthroplasties, which may bias the results.

Excision arthroplasty is the alternative and may be appropriate in patients who are fit for surgery but too frail for prosthesis reimplantation or where there is unreconstructable massive bone loss. Although the procedure provides pain relief, movement is inferior compared to revision arthroplasty, and infection may persist in up to a third of patients.16,21

9. Which antibiotics are recommended?

Decisions regarding antibiotic type, delivery and duration should be made by a multi-disciplinary team on a case by case basis. The involvement of an experienced bacteriologist is mandatory. Isolation of the infecting organism and identification of sensitivities is critical. If unknown, empirical treatment should cover P. acnes and Gram-positive organisms (e.g. vancomycin in combination with a β-lactam).51 Propionibacterium acnes is sensitive to fluoroquinolones, β-lactams and rifampicin,52 although treatment efficacy may be increased using combination therapy with rifampicin and daptomycin.53 If the organism is resistant to rifampicin or ciprofloxacin, linezolid may be considered.54

There are two schools of thought regarding the mode of delivery and length of treatment. We treat these infections aggressively with long-term antibiotics delivered via a percutaneous intravenous catheter (i.e. a PIC line). Inflammatory markers are monitored and, when normalized in conjunction with absent clinical signs of infection, antibiotics are converted to an appropriate oral regime. The alternative approach is based on the view that this is a soft tissue infection because all metalwork and cement has been removed during first-stage revision. Short-term intravenous and oral antibiotics are consequently considered sufficient.

10. How much clinical improvement is likely following either one- or two-stage revision arthroplasty?

Functional scores, pain and range of movement are likely to improve in the mid-term. The aforementioned study by Cuff et al.10 reported that 90% of patients experience an improvement in shoulder abduction (mean improvement for the whole population from 36.1° to 75.7°) and forward flexion improves for 86% (mean 43.1° to 79.5°).10 Mean visual analogue score decreased from 6.3 to 3.5. In another study, the Constant score improved by 31.5 following one-stage procedures and by 20 for two-stage procedures.21

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

  • 1.National Joint Registry. Details for shoulder revision procedures in 2013. Available at: http://www.njrreports.org.uk/shoulders-primary-procedures-activity/S01v1NJR?reportid=47D486B5-59DB-411A-A0C8C854F9FDB804&defaults=J__Filter__Calendar_Year,H__Filter__Joint (accessed 10 May 2015).
  • 2.Piper KE, Fernandez-Sampedro M, Steckelberg KE, et al. C-reactive protein erythrocyte sedimentation rate and orthopedic implant infection. PLoS ONE 2010; 5: e9358–e9358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Dilisio MF, Miller LR, Warner JJP, et al. Arthroscopic tissue culture for the evaluation of periprosthetic shoulder infection. JBJS Am 2014; 96: 1952–8. [DOI] [PubMed] [Google Scholar]
  • 4.Bohsali KI, Wirth MA, Rockwood CA. Complications of total shoulder arthroplasty. J Bone Joint Surg Am 2006; 88: 2279–92. [DOI] [PubMed] [Google Scholar]
  • 5.Cheung EV, Sperling JW, Cofield RH. Infection associated with hematoma formation after shoulder arthroplasty. Clin Orthop 2008; 466: 1363–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Werner CML, Steinmann PA, Gilbart M, et al. Treatment of painful pseudoparesis due to irreparable rotator cuff dysfunction with the Delta III reverse-ball-and-socket total shoulder prosthesis. J Bone Joint Surg Am 2005; 87: 1476–86. [DOI] [PubMed] [Google Scholar]
  • 7.Gerber C, Pennington SD, Nyffeler RW. Reverse total shoulder arthroplasty. J Am Acad Orthop Surg 2009; 17: 284–95. [DOI] [PubMed] [Google Scholar]
  • 8.Boileau P, Watkinson DJ, Hatzidakis AM, et al. Grammont reverse prosthesis: design, rationale, and biomechanics. J Shoulder Elb Surg Am Shoulder Elb Surg Al 2005; 14(1 Suppl S): 147S–61S. [DOI] [PubMed] [Google Scholar]
  • 9.Boileau P, Watkinson D, Hatzidakis AM, et al. Neer Award 2005: The Grammont reverse shoulder prosthesis: results in cuff tear arthritis, fracture sequelae, and revision arthroplasty. J Shoulder Elb Surg Am Shoulder Elb Surg Al 2006; 15: 527–40. [DOI] [PubMed] [Google Scholar]
  • 10.Cuff DJ, Virani NA, Levy J, et al. The treatment of deep shoulder infection and glenohumeral instability with debridement, reverse shoulder arthroplasty and postoperative antibiotics. J Bone Joint Surg Br 2008; 90: 336–42. [DOI] [PubMed] [Google Scholar]
  • 11.Groh GI, Groh GM. Complications rates, reoperation rates, and the learning curve in reverse shoulder arthroplasty. J Shoulder Elb Surg Am Shoulder Elb Surg Al 2014; 23: 388–94. [DOI] [PubMed] [Google Scholar]
  • 12.Florschütz AV, Lane PD, Crosby LA. Infection after primary anatomic versus primary reverse total shoulder arthroplasty. J Shoulder Elb Surg Am Shoulder Elb Surg Al 2015; 24: 1296–301. [DOI] [PubMed] [Google Scholar]
  • 13.Wellmann M, Struck M, Pastor MF, et al. Short and midterm results of reverse shoulder arthroplasty according to the preoperative etiology. Arch Orthop Trauma Surg 2013; 133: 463–71. [DOI] [PubMed] [Google Scholar]
  • 14.National Joint Register. Details for shoulder revision procedures in 2013. 2013. Available from: http://www.njrreports.org.uk/shoulders-revision-procedures/S08v1NJR (accessed 10 May 2015).
  • 15.Richards J, Inacio MCS, Beckett M, et al. Patient and procedure-specific risk factors for deep infection after primary shoulder arthroplasty. Clin Orthop 2014; 472: 2809–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Weber P, Utzschneilder S, Sadohji P, et al. Management of the infected shoulder prosthesis: a retrospective analysis and review of the literature. Int Orthop 2011; 35: 365–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jerosch J, Schneppenheim M. Management of infected shoulder replacement. Arch Orthop Trauma Surg 2003; 123: 209–14. [DOI] [PubMed] [Google Scholar]
  • 18.Werner BC, Burrus MT, Browne JA, et al. Superobesity (body mass index >50 kg/m(2)) and complications after total shoulder arthroplasty: an incremental effect of increasing body mass index. J Shoulder Elb Surg Am Shoulder Elb Surg Al 2015; 24: 1868–75. [DOI] [PubMed] [Google Scholar]
  • 19.Haines JF, Trail IA, Nuttall D, et al. The results of arthroplasty in osteoarthritis of the shoulder. J Bone Joint Surg Br 2006; 88: 496–501. [DOI] [PubMed] [Google Scholar]
  • 20.Boileau P, Sinnerton RJ, Chuinard C, et al. Arthroplasty of the shoulder. J Bone Joint Surg Br 2006; 88: 562–75. [DOI] [PubMed] [Google Scholar]
  • 21.Coste JS, Trojani C, Berg M, et al. The management of infection in arthroplasty of the shoulder. JBJS Br 2004; 86-B: 65–9. [PubMed] [Google Scholar]
  • 22.Sperling JW, Kozak TK, Hanssen AD, et al. Infection after shoulder arthroplasty. Clin Orthop 2001; 382: 206–16. [DOI] [PubMed] [Google Scholar]
  • 23.Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 2005; 135: 243–51. [DOI] [PubMed] [Google Scholar]
  • 24.Grosso MJ, Frangiamore SJ. Sensitivity of frozen section histology for identifying propionibacterium acnes infections in revision shoulder arthroplasty. JBJS Am 2014; 96: 442–7. [DOI] [PubMed] [Google Scholar]
  • 25.Piper KE, Jacobson MJ, Cofield RH, et al. Microbiological diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol 2009; 47: 1878–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Singh JA, Sperling JW, Schleck C, et al. Periprosthetic infections after shoulder hemiarthroplasty. J Shoulder Elb Surg Am Shoulder Elb Surg Al 2012; 21: 1304–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sabesan VJ, Ho JC, Kovacevic D, et al. Two-stage reimplantation for treating prosthetic shoulder infections. Clin Orthop 2011; 469: 2538–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Morman M, Fowler RL, Sanofsky B, et al. Arthroscopic tissue biopsy for evaluation of infection before revision arthroplasty. J Shoulder Elb Surg Am Shoulder Elb Surg Al 2011; 20: e15–22. [DOI] [PubMed] [Google Scholar]
  • 29.Grosso MJ, Frangiamore SJ, Saleh A, et al. Poor utility of serum interleukin-6 levels to predict indolent periprosthetic shoulder infections. J Shoulder Elb Surg 2014; 23: 1277–81. [DOI] [PubMed] [Google Scholar]
  • 30.Wiater BP, Moravek JE, Wiater JM. The evaluation of the failed shoulder arthroplasty. J Shoulder Elb Surg Am Shoulder Elb Surg Al 2014; 23: 745–58. [DOI] [PubMed] [Google Scholar]
  • 31.Portillo ME, Salvadó M, Alier A, et al. Prosthesis failure within 2 years of implantation is highly predictive of infection. Clin Orthop 2013; 471: 3672–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Familiari F, Borade AU, Gonzalez-Zapata A, et al. Algorithm for the evaluation of the painful total shoulder arthroplasty: Searching for sepsis. Semin Arthroplasty 2014; 25: 295–304. [Google Scholar]
  • 33.Matsen FA, Butler-Wu S, Carofino BC, et al. Origin of propionibacterium in surgical wounds and evidence-based approach for culturing propionibacterium from surgical sites. J Bone Joint Surg Am 2013; 95: e1811–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Schäfer P, Fink B, Sandow D, et al. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis Off Publ Infect Dis Soc Am 2008; 47: 1403–9. [DOI] [PubMed] [Google Scholar]
  • 35.Lutz M-F, Berthelot P, Fresard A, et al. Arthroplastic and osteosynthetic infections due to Propionibacterium acnes: a retrospective study of 52 cases, 1995-2002. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 2005; 24: 739–44. [DOI] [PubMed] [Google Scholar]
  • 36.Millett PJ, Yen Y-M, Price CS, et al. Propionibacterium acnes infection as an occult cause of postoperative shoulder pain: a case series. Clin Orthop 2011; 469: 2824–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mook WR, Garrigues GE. Diagnosis and management of periprosthetic shoulder infections. J Bone Joint Surg Am 2014; 96: 956–65. [DOI] [PubMed] [Google Scholar]
  • 38.Butler-Wu SM, Burns EM, Pottinger PS, et al. Optimization of periprosthetic culture for diagnosis of Propionibacterium acnes prosthetic joint infection. J Clin Microbiol 2011; 49: 2490–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Deirmengian C, Kardos K, Kilmartin P, et al. Combined measurement of synovial fluid α-defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection. J Bone Joint Surg Am 2014; 96: 1439–45. [DOI] [PubMed] [Google Scholar]
  • 40.Deirmengian C, Kardos K, Kilmartin P, et al. The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip. Clin Orthop Relat Res 2015; 473: 198–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Bingham J, Clarke H, Spangehl M, et al. The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty. Clin Orthop Relat Res 2014; 472: 4006–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Frangiamore SJ, Saleh A, Grosso MJ, et al. α-Defensin as a predictor of periprosthetic shoulder infection. J Shoulder Elb Surg 2015; 24: 1021–7. [DOI] [PubMed] [Google Scholar]
  • 43.Frangiamore SJ, Saleh A, Kovac MF, et al. Synovial fluid interleukin-6 as a predictor of periprosthetic shoulder infection. JBJS Am 2015; 97: 63–70. [DOI] [PubMed] [Google Scholar]
  • 44.Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Workshop of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011; 469: 2992–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Romanò CL, Borens O, Monti L, et al. What treatment for periprosthetic shoulder infection? Results from a multicentre retrospective series. Int Orthop 2012; 36: 1011–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Beekman PDA, Katusic D, Berghs BM, et al. One-stage revision for patients with a chronically infected reverse total shoulder replacement. J Bone Joint Surg Br 2010; 92: 817–22. [DOI] [PubMed] [Google Scholar]
  • 47.Ince A, Seemann K, Frommelt L, et al. One-stage exchange shoulder arthroplasty for peri-prosthetic infection. J Bone Joint Surg Br 2005; 87: 814–8. [DOI] [PubMed] [Google Scholar]
  • 48.Klatte TO, Junghans K, Al-Khateeb H, et al. Single-stage revision for peri-prosthetic shoulder infection: outcomes and results. Bone Joint J 2013; 95B: 391–5. [DOI] [PubMed] [Google Scholar]
  • 49.Ghijselings S, Stuyck J, Debeer P. Surgical treatment algorithm for infected shoulder arthroplasty: a retrospective analysis of 17 cases. Acta Orthop Belg 2013; 79: 626–35. [PubMed] [Google Scholar]
  • 50.Strickland JP, Sperling JW, Cofield RH. The results of two-stage re-implantation for infected shoulder replacement. J Bone Joint Surg Br 2008; 90: 460–5. [DOI] [PubMed] [Google Scholar]
  • 51.Marschall J, Lane MA, Beekmann SE, et al. Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey. Int J Antimicrob Agents 2013; 41: 272–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Achermann Y, Goldstein EJC, Coenye T, et al. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev 2014; 27: 419–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Saper D, Capiro N, Ma R, et al. Management of Propionibacterium acnes infection after shoulder surgery. Curr Rev Musculoskelet Med 2015; 8: 67–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Morata L, Senneville E, Bernard L, et al. A retrospective review of the clinical experience of linezolid with or without rifampicin in prosthetic joint infections treated with debridement and implant retention. Infect Dis Ther 2014; 3: 235–43. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Shoulder & Elbow are provided here courtesy of SAGE Publications

RESOURCES